Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 13 studies | 36% ± 10% | |
| astrocyte | 10 studies | 36% ± 15% | |
| macrophage | 6 studies | 23% ± 6% | |
| glutamatergic neuron | 4 studies | 23% ± 8% | |
| mast cell | 3 studies | 39% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 7 studies | 26% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1957.88 | 245 / 245 | 100% | 34.67 | 502 / 502 |
| breast | 99% | 817.83 | 454 / 459 | 98% | 13.06 | 1094 / 1118 |
| bladder | 100% | 702.43 | 21 / 21 | 96% | 8.91 | 486 / 504 |
| thymus | 100% | 570.73 | 651 / 653 | 97% | 6.89 | 584 / 605 |
| intestine | 100% | 642.60 | 963 / 966 | 96% | 5.16 | 508 / 527 |
| esophagus | 99% | 659.38 | 1436 / 1445 | 96% | 7.01 | 176 / 183 |
| stomach | 100% | 516.92 | 358 / 359 | 94% | 5.19 | 270 / 286 |
| uterus | 99% | 599.81 | 169 / 170 | 95% | 9.04 | 434 / 459 |
| ovary | 100% | 1115.08 | 180 / 180 | 93% | 5.51 | 401 / 430 |
| lung | 99% | 619.18 | 575 / 578 | 93% | 6.32 | 1079 / 1155 |
| brain | 98% | 620.91 | 2593 / 2642 | 93% | 5.63 | 656 / 705 |
| skin | 84% | 1328.27 | 1512 / 1809 | 93% | 10.93 | 439 / 472 |
| pancreas | 88% | 298.00 | 290 / 328 | 87% | 4.29 | 155 / 178 |
| liver | 100% | 467.44 | 225 / 226 | 72% | 3.25 | 294 / 406 |
| kidney | 94% | 308.73 | 84 / 89 | 62% | 2.36 | 561 / 901 |
| adrenal gland | 93% | 317.55 | 239 / 258 | 45% | 1.49 | 103 / 230 |
| spleen | 100% | 784.93 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 11.54 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 2.31 | 1 / 1 |
| blood vessel | 100% | 628.23 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 854.32 | 915 / 929 | 0% | 0 | 0 / 0 |
| adipose | 98% | 525.73 | 1184 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 96% | 428.36 | 772 / 803 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 3.67 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 78% | 4.14 | 62 / 80 |
| heart | 61% | 165.87 | 521 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0007283 | Biological process | spermatogenesis |
| GO_0048041 | Biological process | focal adhesion assembly |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0004713 | Molecular function | protein tyrosine kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0004672 | Molecular function | protein kinase activity |
| Gene name | TESK2 |
| Protein name | Dual specificity testis-specific protein kinase 2 (EC 2.7.12.1) (Testicular protein kinase 2) |
| Synonyms | |
| Description | FUNCTION: Dual specificity protein kinase activity catalyzing autophosphorylation and phosphorylation of exogenous substrates on both serine/threonine and tyrosine residues. Phosphorylates cofilin at 'Ser-3'. May play an important role in spermatogenesis. |
| Accessions | Q96S53 ENST00000372086.4 [Q96S53-1] ENST00000372084.5 [Q96S53-3] |
